CAJ | 학술논문

目的了解长沙市3家医院老年病科门诊良性前列腺增生(BPH)患者的基本情况及药物应用情况. 方法采用BPH诊断情况日报表、BPH患者就医需求问卷、国际前列腺症状评分(IPSS)表、BPH患者生活质量量表(BPHQLS)对单月在湘雅医院、湘雅二医院、长沙市三医院3家医院老年病科门诊就诊的BPH患者进行调查. 结果 2008年单月3家医院老年病科门诊患者总计657人,其中男性456人,女性201人.诊断为BPH者289人,占老年病科就诊患者的44.0%,占男性患者的63.4%.完成全部调查项目者145人,平均年龄(77.2±5.7)岁,前列腺体积平均值(41.44±21.00)ml,血清前列腺特异抗原(PSA)中位数值2.24 μg/L,最大尿流率(12.65±5.74)ml/S,IPSS评分(14.80±8.11)分,BPHQLS评分(2.56±1.36)分.145例患者中,药物治疗率为66.21%(96/145),α受体阻滞剂单用率为6.90%(10/145),5α还原酶抑制剂单用率为8.97%(13/145),联合治疗方案采用率达26.90%(39/145). 结论 3家医院的门诊BPH患者为高进展风险人群,患者目前治疗方案以药物治疗为主,药物的选择基本合理.
목적 료해장사시3가의원노년병과문진량성전렬선증생(BPH)환자적기본정황급약물응용정황. 방법 채용BPH진단정황일보표、BPH환자취의수구문권、국제전렬선증상평분(IPSS)표、BPH환자생활질량량표(BPHQLS)대단월재상아의원、상아이의원、장사시삼의원3가의원노년병과문진취진적BPH환자진행조사. 결과 2008년단월3가의원노년병과문진환자총계657인,기중남성456인,녀성201인.진단위BPH자289인,점노년병과취진환자적44.0%,점남성환자적63.4%.완성전부조사항목자145인,평균년령(77.2±5.7)세,전렬선체적평균치(41.44±21.00)ml,혈청전렬선특이항원(PSA)중위수치2.24 μg/L,최대뇨류솔(12.65±5.74)ml/S,IPSS평분(14.80±8.11)분,BPHQLS평분(2.56±1.36)분.145례환자중,약물치료솔위66.21%(96/145),α수체조체제단용솔위6.90%(10/145),5α환원매억제제단용솔위8.97%(13/145),연합치료방안채용솔체26.90%(39/145). 결론 3가의원적문진BPH환자위고진전풍험인군,환자목전치료방안이약물치료위주,약물적선택기본합리.
Objective To understand the elementary information and pharmacotherapy for benign prostatic hyperplasia (BPH) in outpatients in geriatrics department of three hospitals. Methods The outpatients diagnosed as BPH were investigated by daily BPH diagnosis report form, BPH medical-care requirement questionnaire, international prostate symptom score (IPSS) questionnaire and BPH quality of life scale (BPHQLS) in odd months. Results There were 657 outpatients in the three hospitals, including 456 males and 201 females. 289 patients were diagnosed as BPH, accounting for 44% of all outpatients and 63.4% of male patients. The average age of BPH patients was (77.2±5.7)years, the mean volume of prostate was (41.44 ± 21.00)ml, the median value of prostate specific antigen (PSA) was 2.24 μg/L, the mean maximum flow rate was (12. 65± 5.74)ml/s, and the average of IPSS and BPHQLS were 14.8±8. 11, 2. 56±1.36, respectively. The percentage of pharmacotherapy was 66.21% (96/145), and the rates of a-receptor blocker monotherapy and 5α-reduetase inhibitor monotherapy were 6.90% and 8. 97%, respectively. The percentage of drug combination was 26.90%. Conclusions BPH outpatients in geriatrics department of the three hospitals are at high risk, and most of them receive drug therapy. The drug choice is reasonable.